Published in
American Association for the Advancement of Science, Science Translational Medicine, 541(12), 2020
DOI: 10.1126/scitranslmed.abb5883
Links
Tools
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Journal article published in 2020 by
Timothy P. Sheahan 
,
Amy C. Sims ,
Shuntai Zhou ,
Rachel L. Graham ,
Andrea J. Pruijssers ,
Maria L. Agostini,
Sarah R. Leist ,
Alexandra Schäfer ,
Kenneth H. Dinnon ,
Laura J. Stevens ,
James D. Chappell,
Xiaotao Lu ,
Tia M. Hughes ,
Amelia S. George ,
Collin S. Hill
and other authors.
,
Amy C. Sims ,
Shuntai Zhou ,
Rachel L. Graham ,
Andrea J. Pruijssers ,
Maria L. Agostini,
Sarah R. Leist ,
Alexandra Schäfer ,
Kenneth H. Dinnon ,
Laura J. Stevens ,
James D. Chappell,
Xiaotao Lu ,
Tia M. Hughes ,
Amelia S. George ,
Collin S. Hill
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
A ribonucleoside analog inhibits SARS-CoV-2 in human airway epithelial cell cultures and SARS-CoV and MERS-CoV in mice.